{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:33:53Z","timestamp":1793104433801,"version":"4.5.0"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01NS138370-01A1"],"award-info":[{"award-number":["1R01NS138370-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_nipt-2024-0019_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Traumatic brain injury (TBI) is a major cause of mortality and long-term neurological disabilities. Adenosine monophosphate-activated protein kinase (AMPK), a key cellular energy sensor, plays a critical role in maintaining energy homeostasis. Loss of AMPK phosphorylation following TBI impairs the restoration of cellular energy homeostasis and promotes inflammation. In this study, we investigated whether post-TBI loss of AMPK worsens functional impairments, amplifies inflammation, and exacerbates tissue damage in a mouse model of TBI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_nipt-2024-0019_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult male C57BL\/6 wild-type (WT) and (AMPK\u03b11-KO) mice were subjected to TBI or sham surgery. Behavioral assessments were performed at 24 h post-TBI, followed by mice were anesthetized, and their brains were rapidly collected for histological and biochemical analyses. To further support our findings, mixed glial cells isolated from WT and AMPK\u03b11-KO pups were treated with lipopolysaccharides and interferon-gamma (LI) (0.1 \u03bcg\/ml LPS and 20 ng\/ml IFNg) for 6 h to induce an inflammatory response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_nipt-2024-0019_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our results show that TBI reduces AMPK phosphorylation in WT mice and that AMPK loss correlates with worsened behavioral deficits, enhanced NLRP3 inflammasome activation, and elevated levels of pro-inflammatory mediators, including IL-1\u03b2. Similarly, AMPK\u03b11-KO glial cells exhibited greater activation of NLRP3 inflammasome and higher expression of pro-inflammatory markers, such as IL-1\u03b2, IL-6, TNF-\u03b1, iNOS, and Cox 2, compared with WT cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_nipt-2024-0019_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, our results demonstrate that AMPK\u03b11 is a critical endogenous regulator of glial-driven neuroinflammation and secondary tissue damage following TBI. Restoring AMPK\u03b11 activity after TBI may therefore represent a promising therapeutic strategy to attenuate neuroinflammation and limit TBI-associated neurological damage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/nipt-2024-0019","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T17:02:07Z","timestamp":1772298127000},"page":"93-104","source":"Crossref","is-referenced-by-count":1,"title":["Loss of\u00a0AMPK potentiates inflammation by\u00a0activating the\u00a0infammasome in\u00a0a preclinical mouse model of\u00a0TBI"],"prefix":"10.1515","volume":"5","author":[{"given":"Mohammad Ejaz","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Neurology , Henry Ford Health , Detroit , MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Suhail","sequence":"additional","affiliation":[{"name":"Department of Neurology , Henry Ford Health , Detroit , MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nematullah","sequence":"additional","affiliation":[{"name":"Department of Neurology , Henry Ford Health , Detroit , MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Viollet","sequence":"additional","affiliation":[{"name":"Universite Paris Cite, CNRS, Inserm, Institute Cochin , Paris , France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Giri","sequence":"additional","affiliation":[{"name":"Department of Neurology , Henry Ford Health , Detroit , MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Shafique","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Neurology , Henry Ford Health , Detroit , MI , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"2026042921060811860_j_nipt-2024-0019_ref_001","doi-asserted-by":"crossref","unstructured":"Barlow, KM, Esser, MJ, Veidt, M, Boyd, R. Melatonin as a treatment after traumatic brain injury: a systematic review and meta-analysis of the pre-clinical and clinical literature. J Neurotrauma 2019;36:523\u201337. https:\/\/doi.org\/10.1089\/neu.2018.5752.","DOI":"10.1089\/neu.2018.5752"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_002","doi-asserted-by":"crossref","unstructured":"Maas, AIR, Menon, DK, Adelson, PD, Andelic, N, Bell, MJ, Belli, A, et al.. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol 2017;16:987\u20131048. https:\/\/doi.org\/10.1016\/s1474-4422(17)30371-x.","DOI":"10.1016\/S1474-4422(17)30371-X"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_003","doi-asserted-by":"crossref","unstructured":"Hovda, DA, Lee, S, Smith, M, Von Stuck, S, Bergsneider, M, Kelly, D, et al.. The neurochemical and metabolic cascade following brain injury: moving from animal models to man. J Neurotrauma 1995;12:903\u20136. https:\/\/doi.org\/10.1089\/neu.1995.12.903.","DOI":"10.1089\/neu.1995.12.903"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_004","doi-asserted-by":"crossref","unstructured":"Yoshino, A, Hovda, DA, Kawamata, T, Katayama, Y, Becker, DP. Dynamic changes in local cerebral glucose utilization following cerebral conclusion in rats: evidence of a hyper- and subsequent hypometabolic state. Brain Res 1991;561:106\u201319. https:\/\/doi.org\/10.1016\/0006-8993(91)90755-k.","DOI":"10.1016\/0006-8993(91)90755-K"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_005","doi-asserted-by":"crossref","unstructured":"Vespa, P, Bergsneider, M, Hattori, N, Wu, HM, Huang, SC, Martin, NA, et al.. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cerebr Blood Flow Metabol 2005;25:763\u201374. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600073.","DOI":"10.1038\/sj.jcbfm.9600073"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_006","doi-asserted-by":"crossref","unstructured":"Gusarova, GA, Trejo, HE, Dada, LA, Briva, A, Welch, LC, Hamanaka, RB, et al.. Hypoxia leads to Na, K-ATPase downregulation via Ca(2+) release-activated Ca(2+) channels and AMPK activation. Mol Cell Biol 2011;31:3546\u201356. https:\/\/doi.org\/10.1128\/mcb.05114-11.","DOI":"10.1128\/MCB.05114-11"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_007","doi-asserted-by":"crossref","unstructured":"Mungai, PT, Waypa, GB, Jairaman, A, Prakriya, M, Dokic, D, Ball, MK, et al.. Hypoxia triggers AMPK activation through reactive oxygen species-mediated activation of calcium release-activated calcium channels. Mol Cell Biol 2011;31:3531\u201345. https:\/\/doi.org\/10.1128\/mcb.05124-11.","DOI":"10.1128\/MCB.05124-11"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_008","doi-asserted-by":"crossref","unstructured":"Concannon, CG, Tuffy, LP, Weisov\u00e1, P, Bonner, HP, D\u00e1vila, D, Bonner, C, et al.. AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis. J Cell Biol 2010;189:83\u201394. https:\/\/doi.org\/10.1083\/jcb.200909166.","DOI":"10.1083\/jcb.200909166"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_009","doi-asserted-by":"crossref","unstructured":"Karagounis, LG, Hawley, JA. The 5\u2032 adenosine monophosphate-activated protein kinase: regulating the ebb and flow of cellular energetics. Int J Biochem Cell Biol 2009;41:2360\u20133. https:\/\/doi.org\/10.1016\/j.biocel.2009.07.004.","DOI":"10.1016\/j.biocel.2009.07.004"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_010","doi-asserted-by":"crossref","unstructured":"Peixoto, CA, Oliveira, WH, Araujo, S, Nunes, AKS. AMPK activation: role in the signaling pathways of neuroinflammation and neurodegeneration. Exp Neurol 2017;298:31\u201341. https:\/\/doi.org\/10.1016\/j.expneurol.2017.08.013.","DOI":"10.1016\/j.expneurol.2017.08.013"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_011","doi-asserted-by":"crossref","unstructured":"Hill, JL, Kobori, N, Zhao, J, Rozas, NS, Hylin, MJ, Moore, AN, et al.. Traumatic brain injury decreases AMP-activated protein kinase activity and pharmacological enhancement of its activity improves cognitive outcome. J Neurochem 2016;139:106\u201319. https:\/\/doi.org\/10.1111\/jnc.13726.","DOI":"10.1111\/jnc.13726"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_012","doi-asserted-by":"crossref","unstructured":"Hardie, DG, Ross, FA, Hawley, SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012;13:251\u201362. https:\/\/doi.org\/10.1038\/nrm3311.","DOI":"10.1038\/nrm3311"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_013","doi-asserted-by":"crossref","unstructured":"Hurley, RL, Anderson, KA, Franzone, JM, Kemp, BE, Means, AR, Witters, LA. The Ca2+\/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 2005;280:29060\u20136. https:\/\/doi.org\/10.1074\/jbc.m503824200.","DOI":"10.1074\/jbc.M503824200"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_014","doi-asserted-by":"crossref","unstructured":"Weisova, P, Concannon, CG, Devocelle, M, Prehn, JH, Ward, MW. Regulation of glucose transporter 3 surface expression by the AMP-activated protein kinase mediates tolerance to glutamate excitation in neurons. J Neurosci 2009;29:2997\u20133008. https:\/\/doi.org\/10.1523\/jneurosci.0354-09.2009.","DOI":"10.1523\/JNEUROSCI.0354-09.2009"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_015","doi-asserted-by":"crossref","unstructured":"O\u2019Neill, LA, Hardie, DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013;493:346\u201355. https:\/\/doi.org\/10.1038\/nature11862.","DOI":"10.1038\/nature11862"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_016","doi-asserted-by":"crossref","unstructured":"Steinberg, GR, Schertzer, JD. AMPK promotes macrophage fatty acid oxidative metabolism to mitigate inflammation: implications for diabetes and cardiovascular disease. Immunol Cell Biol 2014;92:340\u20135. https:\/\/doi.org\/10.1038\/icb.2014.11.","DOI":"10.1038\/icb.2014.11"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_017","doi-asserted-by":"crossref","unstructured":"Baroja-Mazo, A, Mart\u00edn-S\u00e1nchez, F, Gomez, AI, Mart\u00ednez, CM, Amores-Iniesta, J, Compan, V, et al.. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol 2014;15:738\u201348. https:\/\/doi.org\/10.1038\/ni.2919.","DOI":"10.1038\/ni.2919"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_018","doi-asserted-by":"crossref","unstructured":"Schroder, K, Zhou, R, Tschopp, J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 2010;327:296\u2013300. https:\/\/doi.org\/10.1126\/science.1184003.","DOI":"10.1126\/science.1184003"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_019","doi-asserted-by":"crossref","unstructured":"Hang, CH, Chen, G, Shi, JX, Zhang, X, Li, JS. Cortical expression of nuclear factor kappaB after human brain contusion. Brain Res 2006;1109:14\u201321. https:\/\/doi.org\/10.1016\/j.brainres.2006.06.045.","DOI":"10.1016\/j.brainres.2006.06.045"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_020","doi-asserted-by":"crossref","unstructured":"Martinon, F, Burns, K, Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002;10:417\u201326. https:\/\/doi.org\/10.1016\/s1097-2765(02)00599-3.","DOI":"10.1016\/S1097-2765(02)00599-3"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_021","doi-asserted-by":"crossref","unstructured":"Ma, J, Xiao, W, Wang, J, Wu, J, Ren, J, Hou, J, et al.. Propofol inhibits NLRP3 inflammasome and attenuates blast-induced traumatic brain injury in rats. Inflammation 2016;39:2094\u2013103. https:\/\/doi.org\/10.1007\/s10753-016-0446-8.","DOI":"10.1007\/s10753-016-0446-8"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_022","doi-asserted-by":"crossref","unstructured":"Wei, X, Hu, CC, Zhang, YL, Yao, SL, Mao, WK. Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury. J Huazhong Univ Sci Technol Med Sci 2016;36:576\u201383. https:\/\/doi.org\/10.1007\/s11596-016-1628-1.","DOI":"10.1007\/s11596-016-1628-1"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_023","doi-asserted-by":"crossref","unstructured":"Qian, H, Li, Q, Shi, W. Hyperbaric oxygen alleviates the activation of NLRP-3-inflammasomes in traumatic brain injury. Mol Med Rep 2017;16:3922\u20138. https:\/\/doi.org\/10.3892\/mmr.2017.7079.","DOI":"10.3892\/mmr.2017.7079"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_024","doi-asserted-by":"crossref","unstructured":"Wallisch, JS, Simon, DW, Bay\u0131r, H, Bell, MJ, Kochanek, PM, Clark, RSB. Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children. Neurocritical Care 2017;27:44\u201350. https:\/\/doi.org\/10.1007\/s12028-017-0378-7.","DOI":"10.1007\/s12028-017-0378-7"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_025","doi-asserted-by":"crossref","unstructured":"Frugier, T, Morganti-Kossmann, MC, O\u2019Reilly, D, McLean, CA. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma 2010;27:497\u2013507. https:\/\/doi.org\/10.1089\/neu.2009.1120.","DOI":"10.1089\/neu.2009.1120"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_026","doi-asserted-by":"crossref","unstructured":"Adamczak, S, Dale, G, de Rivero Vaccari, JP, Bullock, MR, Dietrich, WD, Keane, RW. Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. J Neurosurg 2012;117:1119\u201325. https:\/\/doi.org\/10.3171\/2012.9.jns12815.","DOI":"10.3171\/2012.9.JNS12815"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_027","doi-asserted-by":"crossref","unstructured":"Nath, N, Khan, M, Rattan, R, Mangalam, A, Makkar, RS, Meester, C, et al.. Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity. Biochem Biophys Res Commun 2009;386:16\u201320. https:\/\/doi.org\/10.1016\/j.bbrc.2009.05.106.","DOI":"10.1016\/j.bbrc.2009.05.106"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_028","doi-asserted-by":"crossref","unstructured":"Mangalam, AK, Rattan, R, Suhail, H, Singh, J, Hoda, MN, Deshpande, M, et al.. AMP-activated protein kinase suppresses autoimmune central nervous system disease by regulating M1-type macrophage-Th17 axis. J Immunol 2016;197:747\u201360. https:\/\/doi.org\/10.4049\/jimmunol.1501549.","DOI":"10.4049\/jimmunol.1501549"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_029","doi-asserted-by":"crossref","unstructured":"Jorgensen, SB, Viollet, B, Andreelli, F, Fr\u00f8sig, C, Birk, JB, Schjerling, P, et al.. Knockout of the alpha2 but not alpha1 5\u2032-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 2004;279:1070\u20139. https:\/\/doi.org\/10.1074\/jbc.m306205200.","DOI":"10.1074\/jbc.M306205200"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_030","doi-asserted-by":"crossref","unstructured":"Braun, M, Vaibhav, K, Saad, N, Fatima, S, Brann, DW, Vender, JR, et al.. Activation of myeloid TLR4 mediates T lymphocyte polarization after traumatic brain injury. J Immunol 2017;198:3615\u201326. https:\/\/doi.org\/10.4049\/jimmunol.1601948.","DOI":"10.4049\/jimmunol.1601948"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_031","doi-asserted-by":"crossref","unstructured":"Ahmed, ME, Dong, Y, Lu, Y, Tucker, D, Wang, R, Zhang, Q. Beneficial effects of a CaMKIIalpha inhibitor TatCN21 peptide in global cerebral ischemia. J Mol Neurosci 2017;61:42\u201351. https:\/\/doi.org\/10.1007\/s12031-016-0830-8.","DOI":"10.1007\/s12031-016-0830-8"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_032","doi-asserted-by":"crossref","unstructured":"Vaibhav, K, Braun, M, Alverson, K, Khodadadi, H, Kutiyanawalla, A, Ward, A, et al.. Neutrophil extracellular traps exacerbate neurological deficits after traumatic brain injury. Sci Adv 2020;6:eaax8847. https:\/\/doi.org\/10.1126\/sciadv.aax8847.","DOI":"10.1126\/sciadv.aax8847"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_033","doi-asserted-by":"crossref","unstructured":"Haller, J, Aliczki, M, Gyimesine Pelczer, K. Classical and novel approaches to the preclinical testing of anxiolytics: a critical evaluation. Neurosci Biobehav Rev 2013;37:2318\u201330. https:\/\/doi.org\/10.1016\/j.neubiorev.2012.09.001.","DOI":"10.1016\/j.neubiorev.2012.09.001"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_034","doi-asserted-by":"crossref","unstructured":"Ahmed, ME, Selvakumar, GP, Kempuraj, D, Raikwar, SP, Thangavel, R, Bazley, K, et al.. Glia maturation factor (GMF) regulates microglial expression phenotypes and the associated neurological deficits in a mouse model of traumatic brain injury. Mol Neurobiol 2020;57:4438\u201350. https:\/\/doi.org\/10.1007\/s12035-020-02040-y.","DOI":"10.1007\/s12035-020-02040-y"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_035","doi-asserted-by":"crossref","unstructured":"Yang, SH, Gustafson, J, Gangidine, M, Stepien, D, Schuster, R, Pritts, TA, et al.. A murine model of mild traumatic brain injury exhibiting cognitive and motor deficits. J Surg Res 2013;184:981\u20138. https:\/\/doi.org\/10.1016\/j.jss.2013.03.075.","DOI":"10.1016\/j.jss.2013.03.075"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_036","doi-asserted-by":"crossref","unstructured":"Selvakumar, GP, Ahmed, ME, Iyer, SS, Thangavel, R, Kempuraj, D, Raikwar, SP, et al.. Absence of glia maturation factor protects from axonal injury and motor behavioral impairments after traumatic brain injury. Exp Neurobiol 2020;29:230\u201348. https:\/\/doi.org\/10.5607\/en20017.","DOI":"10.5607\/en20017"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_037","doi-asserted-by":"crossref","unstructured":"Vaibhav, K, Shrivastava, P, Khan, A, Javed, H, Tabassum, R, Ahmed, ME, et al.. Azadirachta indica mitigates behavioral impairments, oxidative damage, histological alterations and apoptosis in focal cerebral ischemia-reperfusion model of rats. Neurol Sci 2013;34:1321\u201330. https:\/\/doi.org\/10.1007\/s10072-012-1238-z.","DOI":"10.1007\/s10072-012-1238-z"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_038","doi-asserted-by":"crossref","unstructured":"Ahmed, ME, Tucker, D, Dong, Y, Lu, Y, Zhao, N, Wang, R, et al.. Methylene blue promotes cortical neurogenesis and ameliorates behavioral deficit after photothrombotic stroke in rats. Neuroscience 2016;336:39\u201348. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.08.036.","DOI":"10.1016\/j.neuroscience.2016.08.036"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_039","doi-asserted-by":"crossref","unstructured":"Zhao, N, Zhuo, X, Lu, Y, Dong, Y, Ahmed, ME, Tucker, D, et al.. Intranasal delivery of a caspase-1 inhibitor in the treatment of global cerebral ischemia. Mol Neurobiol 2017;54:4936\u201352. https:\/\/doi.org\/10.1007\/s12035-016-0034-9.","DOI":"10.1007\/s12035-016-0034-9"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_040","doi-asserted-by":"crossref","unstructured":"Giri, S, Khan, M, Nath, N, Singh, I, Singh, AK. The role of AMPK in psychosine mediated effects on oligodendrocytes and astrocytes: implication for Krabbe disease. J Neurochem 2008;105:1820\u201333. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05279.x.","DOI":"10.1111\/j.1471-4159.2008.05279.x"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_041","doi-asserted-by":"crossref","unstructured":"Giri, S, Khan, M, Rattan, R, Singh, I, Singh, AK. Krabbe disease: psychosine-mediated activation of phospholipase A2 in oligodendrocyte cell death. J Lipid Res 2006;47:1478\u201392. https:\/\/doi.org\/10.1194\/jlr.m600084-jlr200.","DOI":"10.1194\/jlr.M600084-JLR200"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_042","doi-asserted-by":"crossref","unstructured":"Giri, S, Rattan, R, Singh, AK, Singh, I. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma. J Immunol 2004;173:5196\u2013208. https:\/\/doi.org\/10.4049\/jimmunol.173.8.5196.","DOI":"10.4049\/jimmunol.173.8.5196"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_043","doi-asserted-by":"crossref","unstructured":"Suhail, H, Nematullah, M, Rashid, F, Sajad, M, Fatma, M, Singh, J, et al.. An early glycolysis burst in microglia regulates mitochondrial dysfunction in oligodendrocytes under neuroinflammation. iScience 2023;26:107921. https:\/\/doi.org\/10.1016\/j.isci.2023.107921.","DOI":"10.1016\/j.isci.2023.107921"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_044","unstructured":"Giza, CC, Hovda, DA. The neurometabolic cascade of concussion. J Athl Train 2001;36:228\u201335."},{"key":"2026042921060811860_j_nipt-2024-0019_ref_045","doi-asserted-by":"crossref","unstructured":"Irrera, N, Pizzino, G, Cal\u00f2, M, Pallio, G, Mannino, F, Fam\u00e0, F, et al.. Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury. Front Pharmacol 2017;8:459. https:\/\/doi.org\/10.3389\/fphar.2017.00459.","DOI":"10.3389\/fphar.2017.00459"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_046","doi-asserted-by":"crossref","unstructured":"Liu, HD, Li, W, Chen, ZR, Hu, YC, Zhang, DD, Shen, W, et al.. Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neurochem Res 2013;38:2072\u201383. https:\/\/doi.org\/10.1007\/s11064-013-1115-z.","DOI":"10.1007\/s11064-013-1115-z"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_047","doi-asserted-by":"crossref","unstructured":"Xu, X, Yin, D, Ren, H, Gao, W, Li, F, Sun, D, et al.. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Neurobiol Dis 2018;117:15\u201327. https:\/\/doi.org\/10.1016\/j.nbd.2018.05.016.","DOI":"10.1016\/j.nbd.2018.05.016"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_048","doi-asserted-by":"crossref","unstructured":"Yang, F, Qin, Y, Wang, Y, Meng, S, Xian, H, Che, H, et al.. Metformin inhibits the NLRP3 inflammasome via AMPK\/mTOR-dependent effects in diabetic cardiomyopathy. Int J Biol Sci 2019;15:1010\u201319. https:\/\/doi.org\/10.7150\/ijbs.29680.","DOI":"10.7150\/ijbs.29680"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_049","doi-asserted-by":"crossref","unstructured":"Liu, GJ, Tao, T, Wang, H, Zhou, Y, Gao, X, Gao, YY, et al.. Functions of resolvin D1-ALX\/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury. J Neuroinflammation 2020;17:239. https:\/\/doi.org\/10.1186\/s12974-020-01918-x.","DOI":"10.1186\/s12974-020-01918-x"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_050","doi-asserted-by":"crossref","unstructured":"Xu, W, Li, T, Gao, L, Zheng, J, Yan, J, Zhang, J, et al.. Apelin-13\/APJ system attenuates early brain injury via suppression of endoplasmic reticulum stress-associated TXNIP\/NLRP3 inflammasome activation and oxidative stress in a AMPK-dependent manner after subarachnoid hemorrhage in rats. J Neuroinflammation 2019;16:247. https:\/\/doi.org\/10.1186\/s12974-019-1620-3.","DOI":"10.1186\/s12974-019-1620-3"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_051","doi-asserted-by":"crossref","unstructured":"Hernandez-Ontiveros, DG, Tajiri, N, Acosta, S, Giunta, B, Tan, J, Borlongan, CV. Microglia activation as a biomarker for traumatic brain injury. Front Neurol 2013;4:30. https:\/\/doi.org\/10.3389\/fneur.2013.00030.","DOI":"10.3389\/fneur.2013.00030"},{"key":"2026042921060811860_j_nipt-2024-0019_ref_052","doi-asserted-by":"crossref","unstructured":"Diaz-Arrastia, R, Wang, KK, Papa, L, Sorani, MD, Yue, JK, Puccio, AM, et al.. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J Neurotrauma 2014;31:19\u201325. https:\/\/doi.org\/10.1089\/neu.2013.3040.","DOI":"10.1089\/neu.2013.3040"}],"container-title":["NeuroImmune Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2024-0019\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2024-0019\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:07:55Z","timestamp":1777496875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2024-0019\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,23]]},"published-print":{"date-parts":[[2026,3,26]]}},"alternative-id":["10.1515\/nipt-2024-0019"],"URL":"https:\/\/doi.org\/10.1515\/nipt-2024-0019","relation":{},"ISSN":["2750-6665"],"issn-type":[{"value":"2750-6665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]}}}